Adial Pharmaceuticals Ownership | Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals Ownership Summary

Adial Pharmaceuticals is owned by 5.72% institutional investors, 2.24% insiders, and 92.03% retail investors. Vanguard group is the largest institutional shareholder, holding 0.70% of ADIL shares. BlackRock Extended Equity Market K is the top mutual fund, with 0.27% of its assets in Adial Pharmaceuticals shares.

ADIL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Adial Pharmaceuticals	5.72%	2.24%	92.03%
Sector	Healthcare Stocks	42.64%	10.86%	46.50%
Industry	Biotech Stocks	45.45%	10.77%	43.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	156.02K	0.70%	$34.33K
Geode capital management	155.75K	0.70%	$34.26K
Manchester capital management	48.10K	0.45%	$17.00K
Blackrock funding, inc. /de	27.77K	0.26%	$9.82K
Two sigma securities	12.84K	0.12%	$4.54K
Jane street group	12.34K	0.12%	$4.36M
Hrt financial lp	11.19K	0.11%	$3.00K
Private management group	10.00K	0.09%	$3.54K
Ubs group	9.17K	0.04%	$2.02K
Tower research capital llc (trc)	1.37K	0.01%	$484.00

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Manchester capital management	48.10K	0.00%	$17.00K
Two sigma securities	12.84K	0.00%	$4.54K
Private management group	10.00K	0.00%	$3.54K
Two sigma investments, lp	-	-	-
Harbour investments	99.00	-	$22.00
Virtu financial	-	-	-
1620 investment advisors	-	-	-
Ubs group	9.17K	-	$2.02K
Abound wealth management	27.00	-	$6.00
Wells fargo & company/mn	160.00	-	$57.00

Top Buyers

Holder	Shares	% Assets	Change
Two sigma securities	12.84K	0.00%	12.84K
Private management group	10.00K	0.00%	10.00K
Harbour investments	99.00	-	99.00
Abound wealth management	27.00	-	-
Manchester capital management	48.10K	0.00%	-

Top Sellers

Holder	Shares	% Assets	Change
Virtu financial	-	-	-26.41K
Jane street group	12.34K	-	-12.52K
Two sigma investments, lp	-	-	-10.80K
Ubs group	9.17K	-	-9.59K
Geode capital management	155.75K	-	-8.38K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma securities	12.84K	0.00%	12.84K	$4.54K
Private management group	10.00K	0.00%	10.00K	$3.54K
Harbour investments	99.00	-	99.00	$22.00

Sold Out

Holder	Change
Stone house investment management	-2.70K
1620 investment advisors	-3.60K
Citigroup	-3.97K
Two sigma investments, lp	-10.80K
Virtu financial	-26.41K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	16	6.67%	608,084	159.09%	5	117.27%	9	28.57%	3	50.00%
Jun 30, 2025	16	23.08%	234,705	-1.48%	2	134.51%	7	16.67%	2	100.00%
Mar 31, 2025	1	-	3,600	-	-	508.75%	-	-100.00%	-	-
Dec 31, 2024	1	-	3,600	-	-	-	1	-	-	-
Jun 30, 2023	17	-10.53%	2,253,587	-6.89%	8	10.18%	3	-57.14%	6	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BlackRock Extended Equity Market K	17.57K	0.27%	-7.00
Fidelity Extended Market Index	39.94K	0.18%	-281.00
Spartan Extended Market Index Pool E	11.33K	0.17%	295.00
Extended Equity Market Fund K	17.05K	0.11%	-340.00
Spartan Extended Market Index Pool F	12.00K	0.06%	281.00
Fidelity Series Total Market Index	9.16K	0.04%	-
Vanguard Institutional Extnd Mkt Idx Tr	9.04K	0.04%	-4.12K
Fidelity Total Market Index	7.75K	0.04%	-
Extended Equity Market Fund M	2.15K	0.01%	-31.00
Fidelity Nasdaq Composite Index	661.00	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 29, 2023	Schuyler Kevin	-	Buy	$1.92K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$27.10K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$13.60K
Dec 30, 2021	Newman James W. Jr.	-	Buy	$26.60K
Nov 30, 2021	Stilley William B. III	Chief Executive Officer	Buy	$29.18K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q1	-	-
2023 Q3	1	-
2023 Q2	-	-
2022 Q4	-	-

ADIL Ownership FAQ

Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals shareholders are primarily institutional investors at 5.72%, followed by 2.24% insiders and 92.04% retail investors. The average institutional ownership in Adial Pharmaceuticals's industry, Biotech Stocks , is 45.45%, which Adial Pharmaceuticals falls below.

Who owns the most shares of Adial Pharmaceuticals?

Adial Pharmaceuticals’s largest shareholders are Vanguard group (156.02K shares, 0.70%), Geode capital management (155.74K shares, 0.70%), and Manchester capital management (48.1K shares, 0.45%). Together, they hold 1.86% of Adial Pharmaceuticals’s total shares outstanding.

Does Blackrock own Adial Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Adial Pharmaceuticals.

Who is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Manchester capital management is Adial Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 48.1K Adial Pharmaceuticals shares, valued at 17K$.

Who is the top mutual fund holder of Adial Pharmaceuticals shares?

BlackRock Extended Equity Market K is the top mutual fund holder of Adial Pharmaceuticals shares, with 0.27% of its total shares outstanding invested in 17.57K Adial Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools